Glenmede Trust Co. NA Trims Stake in Lam Research Corporation $LRCX

Glenmede Trust Co. NA lessened its holdings in Lam Research Corporation (NASDAQ:LRCX) by 13.1% during the 1st quarter, HoldingsChannel.com reports. The firm owned 522,694 shares of the semiconductor company’s stock after selling 78,836 shares during the period. Glenmede Trust Co. NA’s holdings in Lam Research were worth $111,679,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of LRCX. Bayban purchased a new stake in Lam Research in the 4th quarter valued at about $26,000. Vermillion Wealth Management Inc. purchased a new position in Lam Research during the first quarter worth about $26,000. Cedar Mountain Advisors LLC boosted its stake in Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after buying an additional 85 shares during the period. Mcguire Capital Advisors Inc. acquired a new stake in shares of Lam Research during the fourth quarter valued at about $27,000. Finally, Triumph Capital Management acquired a new stake in shares of Lam Research during the third quarter valued at about $27,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Strong fiscal fourth-quarter results and outlook: Lam reported record revenue of $6.72 billion, up approximately 30% year over year, and adjusted EPS of $1.82 versus the $1.69 consensus estimate. Management’s outlook for the next quarter—approximately $8.1 billion in revenue and $2.00–$2.30 in EPS—significantly exceeded expectations. NAND revenue more than doubled sequentially, while customer-support revenue reached another record. LRCX Q4 Earnings Beat on NAND and Customer Support Strength
• Positive Sentiment: AI and memory demand remain key catalysts: Analysts and investors see Lam benefiting from ongoing AI infrastructure spending, advanced chip production, NAND investment, packaging, and wafer-fabrication demand. Some commentary describes an “extraordinary runway” heading into 2027. This Chip Stock Could Be the Biggest Winner of the AI Memory Boom
• Positive Sentiment: China memory concerns may be overstated: Mizuho argued that fears of Chinese producer CXMT flooding the DRAM market and pressuring prices are overblown, easing a potential risk to semiconductor-equipment demand. Tech specialist explains why China memory fears are overblown
• Neutral Sentiment: Analyst views remain broadly constructive but targets are mixed: Needham reaffirmed a Buy rating and $390 target, while Morgan Stanley lowered its target from $404 to $367 and B. Riley reduced its target from $385 to $350, retaining Buy or Overweight ratings. The target cuts suggest expectations are being moderated after the rally, even though analysts still see potential upside. Needham Raises Lam Research EPS Estimates
• Negative Sentiment: Valuation and insider selling are overhangs: After rising roughly 3.9 times over five years and trading at a high earnings multiple, LRCX may be vulnerable to profit-taking. Reported insider activity shows sales rather than purchases over the past six months, reinforcing caution around current valuation. Has Lam Research Fallen Far Enough to Look Like a Bargain?

Lam Research Trading Down 1.5%

Shares of LRCX stock opened at $293.15 on Friday. Lam Research Corporation has a fifty-two week low of $90.93 and a fifty-two week high of $438.50. The company has a 50 day moving average price of $340.82 and a 200 day moving average price of $276.47. The stock has a market capitalization of $366.60 billion, a P/E ratio of 50.89, a price-to-earnings-growth ratio of 1.77 and a beta of 1.80. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.77 and a current ratio of 2.63.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. During the same period in the prior year, the business earned $1.33 EPS. The firm’s quarterly revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities research analysts predict that Lam Research Corporation will post 7.92 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 8th. Stockholders of record on Wednesday, June 17th were paid a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. The ex-dividend date was Wednesday, June 17th. Lam Research’s dividend payout ratio (DPR) is presently 18.06%.

Insider Activity at Lam Research

In other Lam Research news, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the sale, the director owned 199,205 shares in the company, valued at $69,881,114. This represents a 21.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of the stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $309.60, for a total value of $2,371,226.40. Following the completion of the sale, the senior vice president directly owned 58,470 shares in the company, valued at $18,102,312. This represents a 11.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 80,441 shares of company stock worth $27,614,296. Company insiders own 0.31% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on LRCX shares. JPMorgan Chase & Co. upped their price objective on shares of Lam Research from $300.00 to $315.00 and gave the stock an “overweight” rating in a report on Thursday, April 23rd. Evercore reiterated an “outperform” rating and issued a $355.00 target price on shares of Lam Research in a report on Monday, July 20th. B. Riley Financial cut their target price on Lam Research from $385.00 to $350.00 and set a “buy” rating on the stock in a research report on Thursday. Rothschild & Co Redburn upped their price target on Lam Research from $305.00 to $420.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Finally, Raymond James Financial set a $425.00 price target on Lam Research in a research report on Wednesday, June 10th. One analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $358.47.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.